yjbD Antibody

Shipped with Ice Packs
In Stock

Description

Definition and Biological Context of YjbD

YjbD is a protein encoded by the yjbD gene in Bacillus subtilis, a model organism for studying bacterial stress responses and proteolysis mechanisms. The protein is part of the Spx (YjbD) regulon, which regulates redox homeostasis and stress responses. Spx is controlled by ClpP-dependent proteolysis, and YjbD functions as a critical component in modulating Spx degradation under stress conditions .

Research Applications of YjbD Antibody

Antibodies targeting YjbD are primarily used to study its expression, localization, and interaction with proteolytic pathways. Key applications include:

  • Western Blotting: Detecting YjbD protein levels in wild-type versus mutant strains .

  • Immunofluorescence: Localizing YjbD within B. subtilis cells during oxidative stress .

  • Genetic Construct Validation: Confirming gene knockout (e.g., yjbD::neo) or overexpression strains .

Proteolytic Regulation of Spx/YjbD

Studies using yjbD mutants revealed that YjbD stability is influenced by ClpXP, ClpCP, and ClpEP protease complexes. For example:

  • Strain ORB4078 (yjbD::neo amyE::P~spac~-yjbD): Shows altered Spx degradation rates under stress .

  • Strain ORB4080 (yjbD::neo clpP::erm): Demonstrates impaired ClpP-dependent proteolysis, leading to Spx accumulation .

Antibody Characterization Challenges

While no direct data on YjbD antibody performance exists in the provided sources, broader antibody validation frameworks (e.g., YCharOS) highlight critical parameters for reliability :

Validation ParameterRelevance to YjbD Antibody
Knockout (KO) ControlsEssential for confirming specificity in B. subtilis mutants .
Western Blot ReproducibilityRequires consistent protocols to avoid false positives .
Immunofluorescence (IF) SpecificityDependent on cell fixation and permeabilization methods .

Strain-Specific Data Involving YjbD Antibodies

The table below summarizes B. subtilis strains used in YjbD-related studies :

StrainGenotypeKey Phenotype
ORB3834spx::neoSpx knockout, used to study YjbD-Spx interactions
ORB4078yjbD::neo amyE::P~spac~-yjbDConditional YjbD overexpression
ORB4080yjbD::neo clpP::ermImpaired ClpP protease activity, Spx accumulation

Gaps and Future Directions

  • Commercial Availability: No commercial YjbD antibodies are explicitly mentioned in the provided sources. Researchers typically generate custom polyclonal or monoclonal antibodies for specific studies .

  • Validation Needs: Adopting standardized protocols (e.g., YCharOS’s KO cell line validation) could improve reproducibility in B. subtilis research .

Authoritative Recommendations

For researchers investigating YjbD:

  1. Utilize KO Controls: Validate antibody specificity using yjbD knockout strains .

  2. Cross-Reference Databases: Consult resources like YAbS or YCharOS for antibody validation benchmarks.

  3. Publish Characterization Data: Share antibody performance metrics in open repositories (e.g., Zenodo) .

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Components: 50% Glycerol, 0.01M Phosphate Buffered Saline (PBS), pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
yjbD antibody; b4023 antibody; JW3983 antibody; Uncharacterized protein YjbD antibody
Target Names
yjbD
Uniprot No.

Q&A

What is yjbD and where is it found?

yjbD is a bacterial protein predominantly found in Escherichia species, including E. coli. It functions within bacterial cellular processes, and antibodies against this protein are used in various research applications to detect its presence and study its function. When working with yjbD antibodies, it's essential to understand that they are specifically reactive to Escherichia bacterial targets .

What applications are yjbD antibodies suitable for?

Current commercially available yjbD antibodies are primarily validated for Western Blot (WB) and Enzyme-Linked Immunosorbent Assay (ELISA) applications . These applications allow researchers to detect and quantify yjbD protein in bacterial samples. When designing experiments, ensure the selected antibody has been verified for your intended application, as antibody performance can vary significantly between different experimental contexts .

How should I validate a yjbD antibody before use?

Antibody validation is critical for obtaining reliable research results. For yjbD antibodies, validation should include:

  • Specificity testing using positive controls (E. coli extracts containing yjbD)

  • Negative controls (knockout or yjbD-negative bacterial strains)

  • Concentration optimization for your specific application

  • Cross-reactivity testing if working with multiple bacterial species

The "five pillars" approach to antibody validation recommends using genetic strategies (knockout controls), orthogonal strategies (comparing antibody-dependent and independent methods), multiple antibody strategies (using different antibodies targeting the same protein), recombinant expression strategies, and immunocapture-MS strategies where feasible .

What are common troubleshooting issues with yjbD antibodies in Western blots?

When using yjbD antibodies in Western blots, researchers may encounter several common issues:

  • Weak or no signal: May indicate insufficient antibody concentration, degraded protein, or poor transfer efficiency

  • Multiple bands: Could represent non-specific binding, protein degradation, or post-translational modifications

  • High background: Often due to insufficient blocking or excessive antibody concentration

To troubleshoot, optimize blocking conditions (try 5% non-fat milk or BSA), adjust antibody dilutions, increase washing steps, and ensure proper sample preparation to maintain protein integrity .

How does antibody characterization affect research reproducibility with yjbD antibodies?

Research reproducibility with yjbD antibodies directly depends on thorough antibody characterization. Studies have shown that approximately 50% of commercial antibodies fail to meet basic characterization standards, contributing to an estimated $0.4-1.8 billion in financial losses annually in the United States due to irreproducible research .

For yjbD antibodies specifically, comprehensive characterization should document:

  • Binding to the target yjbD protein in isolation

  • Binding to yjbD in complex protein mixtures (bacterial lysates)

  • Absence of binding to non-target proteins

  • Consistent performance under the specific experimental conditions used in your assays

What approaches can be used to enhance the specificity of yjbD antibodies?

Enhancing yjbD antibody specificity can be approached through several strategies:

  • Computational design approaches: Recent advances allow for designing antibodies with customized specificity profiles through biophysics-informed modeling combined with selection experiments .

  • Binding mode identification: Different binding modes can be identified for particular ligands, enabling the design of antibodies that either:

    • Maintain high specificity for yjbD only

    • Develop cross-specificity for multiple targets when needed for comparative studies

  • Recombinant technologies: Recombinant antibodies have been shown to outperform both monoclonal and polyclonal antibodies in specificity tests across multiple assays .

How should I interpret contradictory results obtained with different yjbD antibody lots or sources?

Contradictory results with different yjbD antibody preparations are a common challenge in research. To systematically address this:

  • Document antibody metadata: Record the supplier, catalog number, lot number, and RRID (Research Resource Identifier) for each antibody used .

  • Compare characterization data: Evaluate each antibody's validation data, particularly focusing on the specific application you're using (WB or ELISA for yjbD antibodies) .

  • Conduct parallel validation: Test multiple antibodies simultaneously under identical conditions using proper controls.

  • Consider epitope differences: Different antibodies may recognize different epitopes on the yjbD protein, potentially explaining discrepancies if post-translational modifications or protein interactions are present.

Notably, studies of antibody performance have revealed that an antibody's efficacy can be highly context-dependent, requiring user-specific validation for each experimental context .

What considerations should be made when using yjbD antibodies in complex bacterial communities?

When studying yjbD in complex bacterial communities rather than pure cultures:

  • Cross-reactivity assessment: Thoroughly test for potential cross-reactivity with homologous proteins in other bacterial species present in your samples.

  • Enrichment strategies: Consider enriching for Escherichia species before antibody-based detection if studying communities with low Escherichia abundance.

  • Complementary methods: Combine antibody-based detection with orthogonal methods like PCR-based detection of the yjbD gene to confirm results.

  • Sample preparation optimization: Complex bacterial communities may require modified lysis protocols to efficiently extract proteins while minimizing interfering substances.

What controls are essential when using yjbD antibodies in research?

Essential controls for yjbD antibody experiments include:

  • Positive control: Lysate from E. coli known to express yjbD

  • Negative control:

    • Ideally, a yjbD knockout strain

    • Alternatively, a bacterial species lacking yjbD

  • Loading control: For Western blots, include a housekeeping protein detection

  • Secondary antibody control: Sample without primary antibody to assess non-specific binding

  • Isotype control: For immunofluorescence or flow cytometry applications

The YCharOS initiative has demonstrated that knockout cell lines represent superior controls compared to other control types, particularly for immunofluorescence imaging .

How should yjbD antibody performance be validated across different bacterial growth conditions?

yjbD expression may vary with bacterial growth conditions, affecting antibody detection. A systematic validation approach should:

  • Test antibody performance across different:

    • Growth phases (lag, log, stationary)

    • Media compositions

    • Stress conditions (nutrient limitation, pH changes, etc.)

  • Quantify yjbD expression levels using quantitative Western blotting with purified recombinant yjbD protein standards.

  • Document any variations in antibody performance that correlate with growth conditions.

  • Adjust protocols (antibody concentration, incubation times) to maintain consistent detection across different conditions.

What is the recommended protocol for optimizing yjbD antibody concentration in Western blots?

For optimal Western blot results with yjbD antibodies:

  • Initial titration: Test a range of primary antibody dilutions (1:500 to 1:5000) using a standard E. coli lysate.

  • Signal-to-noise assessment: Calculate the ratio between specific band intensity and background for each dilution.

  • Blocking optimization: Test multiple blocking agents (5% milk, 3-5% BSA) as protein composition can affect antibody performance.

  • Incubation conditions: Compare different incubation times (1 hour at room temperature vs. overnight at 4°C) and washing protocols.

  • Secondary antibody matching: Ensure the secondary antibody concentration is appropriately matched to the primary antibody dilution (typically 1:5000 to 1:20000).

The optimized protocol should yield clear, specific bands with minimal background when detecting yjbD in bacterial samples .

How can yjbD antibodies be used in studies of bacterial stress responses?

yjbD antibodies can provide valuable tools for studying bacterial stress responses by:

  • Monitoring changes in yjbD protein expression levels under various stress conditions using quantitative Western blotting.

  • Combining with transcriptomic approaches to correlate protein levels with gene expression changes.

  • Using immunoprecipitation followed by mass spectrometry to identify stress-specific protein interaction partners of yjbD.

  • Developing time-course studies to track the dynamics of yjbD expression during adaptation to environmental challenges.

What emerging technologies might improve yjbD antibody specificity and sensitivity?

Several emerging technologies show promise for enhancing yjbD antibody research:

  • Recombinant antibody development: Generation of recombinant anti-yjbD antibodies could improve reproducibility, as recombinant antibodies have shown superior performance compared to both polyclonal and monoclonal antibodies in multiple assays .

  • Phage display with computational modeling: This approach enables the design of antibodies with customized specificity profiles, allowing researchers to create anti-yjbD antibodies with either highly specific binding to yjbD or controlled cross-reactivity when needed .

  • CRISPR-based knockout validation: Using CRISPR to generate precise yjbD knockout bacterial strains provides gold-standard negative controls for antibody validation.

  • Single-cell antibody-based detection: Adapting yjbD antibodies for single-cell applications could reveal population heterogeneity in bacterial communities.

How should researchers interpret changes in yjbD antibody binding patterns during bacterial adaptation experiments?

Changes in yjbD antibody binding patterns during adaptation experiments may indicate:

  • Expression level changes: Quantitative differences in band intensity may reflect up- or down-regulation of yjbD.

  • Post-translational modifications: Appearance of additional bands or band shifts might indicate modifications like phosphorylation.

  • Protein degradation: Multiple lower molecular weight bands could suggest protein degradation or processing.

  • Protein-protein interactions: Changes in antibody accessibility could result from new protein-protein interactions.

To properly interpret these changes, researchers should:

  • Use multiple antibodies targeting different yjbD epitopes when possible

  • Combine with proteomic approaches to identify modifications

  • Verify with orthogonal techniques such as mass spectrometry

  • Document all experimental conditions that might influence protein expression or modification

What are the current consensus best practices for yjbD antibody-based research?

Based on current understanding, best practices for yjbD antibody research include:

  • Thorough validation: Utilize knockout controls whenever possible and document antibody performance in your specific experimental context.

  • Metadata documentation: Record complete antibody information including supplier, catalog number, lot number, and RRID in all publications and lab records .

  • Multiple detection methods: Confirm key findings with orthogonal approaches not relying solely on antibody detection.

  • Recombinant antibody preference: When available, select recombinant anti-yjbD antibodies over monoclonal or polyclonal options for improved reproducibility .

  • Appropriate controls: Always include positive and negative controls in every experiment.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.